|
|||||
|
|
HER2/ErbB2 activates HSF1 and thereby controls HSP90 clients including MIF in HER2-overexpressing breast cancer |
|
| Authors: | R Schulz F Streller A H Scheel J Rüschoff M-C Reinert M Dobbelstein N D Marchenko U M Moll |
| Affiliation: | 1.Institute of Molecular Oncology, GZMB, University of Göttingen, Göttingen 37077, Germany;2.Institute for Pathology Nordhessen, Kassel 34119, Germany;3.Department of Pathology, Stony Brook University, Stony Brook, NY 11794, USA |
| Abstract: | |
| Keywords: | MIF HSP90 HSF1 mTOR HER2 ErbB2 |